Cover Image
Market Research Report
Product code 
1027834

Pharmaceutical Intermediates Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Published: | Transparency Market Research | 190 Pages | Delivery time: 1-2 business days

Price

Back to Top
Pharmaceutical Intermediates Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
Published: July 6, 2021
Transparency Market Research
Content info: 190 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Scope of the Report

TMR's report on the global pharmaceutical intermediates market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market over the forecast period from 2021 to 2031. The report provides the overall revenue of the global pharmaceutical intermediates market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global pharmaceutical intermediates market for the forecast period of 2021-2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global pharmaceutical intermediates market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global pharmaceutical intermediates market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the pharmaceutical intermediates market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the pharmaceutical intermediates market.

The report also delves into the competitive landscape of the global pharmaceutical intermediates market. Key players operating in the global pharmaceutical intermediates market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the pharmaceutical intermediates market profiled in this report.

Key Questions Answered:

  • How does the development of pharmaceutical intermediates provide scope of growth in the global pharmaceutical intermediates market?
  • How alliances and partnerships between players are widening the scope of new line of therapies for pharmaceutical intermediates?
  • What are the revenue share projections of key segments under various criteria in the pharmaceutical intermediates market during the forecast period?
  • Which segment is likely to register highest revenue until the end of the forecast period in 2031?
  • How is the evolving health care system in developing countries in Asia Pacific making an impact on the overall pharmaceutical intermediates market?

Research Objectives and Research Approach

The comprehensive report on the global pharmaceutical intermediates market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for pharmaceutical intermediates.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pharmaceutical intermediates market in terms of product, application, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pharmaceutical intermediates market.

Product Code: TMRGL54963

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pharmaceutical Intermediates Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Global Pharmaceutical Intermediates Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
  • 5.2. Key Industry Events (mergers and acquisitions, new product development, etc.)
  • 5.3. Pharmaceutical Intermediates Products/Brands List

6. Global Pharmaceutical Intermediates Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
    • 6.1.1. Key Findings / Developments
  • 6.2. Global Pharmaceutical Intermediates Market Value Forecast, by Product, 2017-2031
    • 6.2.1. Bulk Drug Intermediate
      • 6.2.1.1. Chiral Intermediate
      • 6.2.1.2. Achiral Intermediate
    • 6.2.2. Custom Intermediate
  • 6.3. Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Product

7. Global Pharmaceutical Intermediates Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
    • 7.1.1. Key Findings / Developments
  • 7.2. Global Pharmaceutical Intermediates Market Value Forecast, by Application, 2017-2031
    • 7.2.1. Cardiology
    • 7.2.2. Oncology
    • 7.2.3. Endocrinology
    • 7.2.4. Infectious Diseases
    • 7.2.5. Orthopedics
    • 7.2.6. Neurology
    • 7.2.7. Gastroenterology
    • 7.2.8. Dermatology
    • 7.2.9. Inflammatory & Pain Management
    • 7.2.10. Ophthalmology
    • 7.2.11. Others
  • 7.3. Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Application

8. Global Pharmaceutical Intermediates Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
    • 8.1.1. Key Findings / Developments
  • 8.2. Global Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017-2031
    • 8.2.1. Pharmaceutical & Biotechnology Companies
    • 8.2.2. CROs & CMOs
  • 8.3. Global Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user

9. Global Pharmaceutical Intermediates Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Pharmaceutical Intermediates Market Value Forecast by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Region

10. North America Pharmaceutical Intermediates Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Pharmaceutical Intermediates Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Bulk Drug Intermediate
      • 10.2.1.1. Chiral Intermediate
      • 10.2.1.2. Achiral Intermediate
    • 10.2.2. Custom Intermediate
  • 10.3. North America Pharmaceutical Intermediates Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Cardiology
    • 10.3.2. Oncology
    • 10.3.3. Endocrinology
    • 10.3.4. Infectious Diseases
    • 10.3.5. Orthopedics
    • 10.3.6. Neurology
    • 10.3.7. Gastroenterology
    • 10.3.8. Dermatology
    • 10.3.9. Inflammatory & Pain Management
    • 10.3.10. Ophthalmology
    • 10.3.11. Others
  • 10.4. North America Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. CROs & CMOs
  • 10.5. North America Pharmaceutical Intermediates Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Pharmaceutical Intermediates Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Pharmaceutical Intermediates Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Europe Pharmaceutical Intermediates Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Bulk Drug Intermediate
      • 11.2.1.1. Chiral Intermediate
      • 11.2.1.2. Achiral Intermediate
    • 11.2.2. Custom Intermediate
  • 11.3. Europe Pharmaceutical Intermediates Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Cardiology
    • 11.3.2. Oncology
    • 11.3.3. Endocrinology
    • 11.3.4. Infectious Diseases
    • 11.3.5. Orthopedics
    • 11.3.6. Neurology
    • 11.3.7. Gastroenterology
    • 11.3.8. Dermatology
    • 11.3.9. Inflammatory & Pain Management
    • 11.3.10. Ophthalmology
    • 11.3.11. Others
  • 11.4. Europe Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Pharmaceutical & Biotechnology Companies
    • 11.4.2. CROs & CMOs
  • 11.5. Europe Pharmaceutical Intermediates Market Value Forecast by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Pharmaceutical Intermediates Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Pharmaceutical Intermediates Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Pharmaceutical Intermediates Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Bulk Drug Intermediate
      • 12.2.1.1. Chiral Intermediate
      • 12.2.1.2. Achiral Intermediate
    • 12.2.2. Custom Intermediate
  • 12.3. Asia Pacific Pharmaceutical Intermediates Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Cardiology
    • 12.3.2. Oncology
    • 12.3.3. Endocrinology
    • 12.3.4. Infectious Diseases
    • 12.3.5. Orthopedics
    • 12.3.6. Neurology
    • 12.3.7. Gastroenterology
    • 12.3.8. Dermatology
    • 12.3.9. Inflammatory & Pain Management
    • 12.3.10. Ophthalmology
    • 12.3.11. Others
  • 12.4. Asia Pacific Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Pharmaceutical & Biotechnology Companies
    • 12.4.2. CROs & CMOs
  • 12.5. Asia Pacific Pharmaceutical Intermediates Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Pharmaceutical Intermediates Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Pharmaceutical Intermediates Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Bulk Drug Intermediate
      • 13.2.1.1. Chiral Intermediate
      • 13.2.1.2. Achiral Intermediate
    • 13.2.2. Custom Intermediate
  • 13.3. Latin America Pharmaceutical Intermediates Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Cardiology
    • 13.3.2. Oncology
    • 13.3.3. Endocrinology
    • 13.3.4. Infectious Diseases
    • 13.3.5. Orthopedics
    • 13.3.6. Neurology
    • 13.3.7. Gastroenterology
    • 13.3.8. Dermatology
    • 13.3.9. Inflammatory & Pain Management
    • 13.3.10. Ophthalmology
    • 13.3.11. Others
  • 13.4. Latin America Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Pharmaceutical & Biotechnology Companies
    • 13.4.2. CROs & CMOs
  • 13.5. Latin America Pharmaceutical Intermediates Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Pharmaceutical Intermediates Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Pharmaceutical Intermediates Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Pharmaceutical Intermediates Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Bulk Drug Intermediate
      • 14.2.1.1. Chiral Intermediate
      • 14.2.1.2. Achiral Intermediate
    • 14.2.2. Custom Intermediate
  • 14.3. Middle East & Africa Pharmaceutical Intermediates Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Cardiology
    • 14.3.2. Oncology
    • 14.3.3. Endocrinology
    • 14.3.4. Infectious Diseases
    • 14.3.5. Orthopedics
    • 14.3.6. Neurology
    • 14.3.7. Gastroenterology
    • 14.3.8. Dermatology
    • 14.3.9. Inflammatory & Pain Management
    • 14.3.10. Ophthalmology
    • 14.3.11. Others
  • 14.4. Middle East & Africa Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Pharmaceutical & Biotechnology Companies
    • 14.4.2. CROs & CMOs
  • 14.5. Middle East & Africa Pharmaceutical Intermediates Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis/Ranking, by Company, 2020
  • 15.3. Company Profiles
    • 15.3.1. BASF SE
      • 15.3.1.1. Company Description
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Strategic Overview
      • 15.3.1.4. SWOT Analysis
    • 15.3.2. Lonza Group
      • 15.3.2.1. Company Description
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Strategic Overview
      • 15.3.2.4. SWOT Analysis
    • 15.3.3. Evonik Industries AG
      • 15.3.3.1. Company Description
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Strategic Overview
      • 15.3.3.4. SWOT Analysis
    • 15.3.4. Cambrex Corporation
      • 15.3.4.1. Company Description
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Strategic Overview
      • 15.3.4.4. SWOT Analysis
    • 15.3.5. DSM
      • 15.3.5.1. Company Description
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Strategic Overview
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Aceto
      • 15.3.6.1. Company Description
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Strategic Overview
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. Albemarle Corporation
      • 15.3.7.1. Company Description
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Strategic Overview
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Vertellus
      • 15.3.8.1. Company Description
      • 15.3.8.2. Business Overview
      • 15.3.8.3. Strategic Overview
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Chemcon Speciality Chemicals Ltd.
      • 15.3.9.1. Company Description
      • 15.3.9.2. Business Overview
      • 15.3.9.3. Strategic Overview
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. chiracon GmbH
      • 15.3.10.1. Company Description
      • 15.3.10.2. Business Overview
      • 15.3.10.3. Strategic Overview
      • 15.3.10.4. SWOT Analysis
    • 15.3.11. A. R. Life Sciences Private Limited
      • 15.3.11.1. Company Description
      • 15.3.11.2. Business Overview
      • 15.3.11.3. Strategic Overview
      • 15.3.11.4. SWOT Analysis

List of Tables

  • Table 01: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017-2031
  • Table 03: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 09: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017-2031
  • Table 10: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017-2031
  • Table 16: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 17: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 18: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 21: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017-2031
  • Table 22: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 27: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017-2031
  • Table 28: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 33: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017-2031
  • Table 34: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 35: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 36: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Pharmaceutical Intermediates Market Value Share, by Product, 2020
  • Figure 03: Global Pharmaceutical Intermediates Market Value Share, by Application, 2020
  • Figure 04: Global Pharmaceutical Intermediates Market Value Share, by End-user, 2020
  • Figure 05: Global Pharmaceutical Intermediates Market Value Share, by Region, 2020
  • Figure 06: Global Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 07: Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 08: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Bulk Drug Intermediate, 2017-2031
  • Figure 09: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Custom Intermediate, 2017-2031
  • Figure 10: Global Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 11: Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 12: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Cardiology, 2017-2031
  • Figure 13: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Oncology, 2017-2031
  • Figure 14: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Endocrinology, 2017-2031
  • Figure 15: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Infectious Diseases, 2017-2031
  • Figure 16: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Orthopedics, 2017-2031
  • Figure 17: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Neurology, 2017-2031
  • Figure 18: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Gastroenterology, 2017-2031
  • Figure 19: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Dermatology, 2017-2031
  • Figure 20: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 21: Global Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 22: Global Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 23: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017-2031
  • Figure 24: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by CROs & CMOs, 2017-2031
  • Figure 25: Global Pharmaceutical Intermediates Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 26: Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 27: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 28: North America Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 29: North America Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 30: North America Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 31: North America Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 32: North America Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 33: North America Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 34: North America Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 35: North America Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 36: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Europe Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 38: Europe Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 39: Europe Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 40: Europe Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 41: Europe Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 42: Europe Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 43: Europe Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 44: Europe Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 45: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 46: Asia Pacific Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 47: Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 48: Asia Pacific Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 49: Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 50: Asia Pacific Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 51: Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 52: Asia Pacific Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 53: Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 54: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 55: Latin America Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 56: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 57: Latin America Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 58: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 59: Latin America Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 60: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 61: Latin America Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 62: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 63: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 64: Middle East & Africa Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 65: Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 66: Middle East & Africa Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031
  • Figure 67: Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021-2031
  • Figure 68: Middle East & Africa Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 69: Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 70: Middle East & Africa Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 71: Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021-2031